Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the Record History.SummaryDifference0.8%

- Check21 days agoChange DetectedThe page now displays a government funding notice at the top indicating the NIH Clinical Center is open, and the record version has been updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedA glossary toggle was added and the history section now uses green highlights for additions and red for deletions, with a new Revision: v3.4.0 label replacing v3.3.4.SummaryDifference1%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 in the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRecent history entries show Study Status updates on 2025-12-22 and 2025-12-23. A deletion entry dated 2025-05-02 appears in the version history for NCT05297890.SummaryDifference0.4%

- Check64 days agoChange DetectedAdded an entry 'Revision: v3.3.3' to the Record History and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.